Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world treatment patterns among a contemporary cohort of commercially insured mantle cell lymphoma patients in the United States
    Meeting Abstract

    Roeker, L. E.; Kabadi, S.; Burudpakdee, C.; Near, A.; Wada, K.; Mato, A. R.
    Blood (2018)

    Fulltext@MSK | Save
  • Comparison of costs and health care resource utilization (HRU) in chronic lymphocytic leukemia (CLL) patients treated with venetoclax (VEN) or chemotherapy (CT)/chemoimmunotherapy (CIT)
    Meeting Abstract

    Nabhan, C.; Mato, A. R.; Kish, J. K.; Nero, D.
    Blood (2018)

    Fulltext@MSK | Save
  • Cost-effectiveness comparison between ibrutinib, chemotherapy, and chemoimmunotherapy in front-line treatment of chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Nabhan, C.; Nero, D.; Lee, C. H.; Kish, J. K.; Mato, A. R.
    Blood (2018)

    Fulltext@MSK | Save
  • Impact on MPN symptoms and quality of life of front line pegylated interferon alpha-2a vs. hydroxyurea in high risk polycythemia vera and essential thrombocythemia: Results of myeloproliferative disorders research consortium (MPD-RC) 112 global phase III trial
    Meeting Abstract

    Mesa, R. A.; Kosiorek, H. E.; Mascarenhas, J.; Prchal, J. T.; Rambaldi, A.; Berenzon, D.; Yacoub, A.; Harrison, C. N.; McMullin, M. F.; Vannucchi, A. M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prognostic testing and treatment approaches in patients with chronic lymphocytic leukemia: Clinical experience from an interim analysis of the informCLL (TM) real-world registry
    Meeting Abstract

    Mato, A. R.; Barrientos, J. C.; Brander, D. M.; Pagel, J. M.; Gutierrez, M.; Kadish, K.; Tomlinson, B.; Ghosh, N.; Giafis, N.; Ipe, D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Cardiovascular hospitalization in patients treated with dasatinib or nilotinib in SIMPLICITY, an observational study of chronic-phase chronic myeloid leukemia (CP-CML) patients in routine clinical practice
    Meeting Abstract

    Mauro, M. J.; Chen, C.; Cortes, J. E.; Gambacorti-Passerini, C.; Sen, G. P.; Gajavelli, S.; Davis, C.; Michallet, M.
    Blood (2018)

    Fulltext@MSK | Save
  • Venetoclax as monotherapy or in combination: Patterns of use and predictors of outcomes in an international multicenter study of CLL patients
    Meeting Abstract

    Mato, A. R.; Roeker, L. E.; Eyre, T. A.; Nabhan, C.; Lamanna, N.; Hill, B. T.; Brander, D. M.; Barr, P.; Lansigan, F.; Cheson, B.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • YY1 controls hematopoietic stem cell quiescence by repressing cohesin expression
    Meeting Abstract

    Lu, Z.; Assumpcao, A. L. F. V.; Viny, A. D.; Levine, R. L.; Pan, X.
    Blood (2018)

    Fulltext@MSK | Save
  • Treatment patterns and outcomes of patients with CLL treated with chemoimmuno- and novel agent-based therapy: A multicenter study
    Meeting Abstract

    Mato, A. R.; Yazdy, M. S.; Hill, B. T.; Shadman, M.; Tuncer, H.; Winter, A. M.; Kennard, K.; Allan, J. N.; Ujjani, C. S.; Brander, D. M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Kinetics of BCR-ABL after TKI interruption during pregnancy in CML: A multinational retrospective analysis
    Meeting Abstract

    Lee, J. O.; Kim, D. W.; Abruzzese, E.; Apperley, J.; Caldwell, L.; Mauro, M. J.
    Blood (2018)

    Fulltext@MSK | Save